Tuesday, July 24, 2012 9:38:49 AM
and put the money into Peregrine because I believed so strongly in the biology behind it. I did have a few
rules about what companies I would invest in. One of them is no investments in biotechs who only work on
Alzheimers (sorry Thurly). Another is no anti-depressants, and no obesity drugs! No Alzheimers because
the biology was/is too unknown still. I don't know if what they think they are treating is the symptom or the cause.
Also, as they are finding out, by the time a person shows signs of Alzheimers I think it is too late, which means
you would have to treat much earlier to make a difference, which means trials that would last for 10-20 years! No thanks.
The problem with anti-depressants and other such drugs is also that the biology is too unknown and the data is
too subjective for my tastes. I think obesity drugs are bad too because I think they are going to have too
many side effects for a non-fatal (at least in the short term) condition to be useful.
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
